Placebo, nocebo e relazione terapeuta-paziente
Ziele
Mentre la medicina molecolare ha compiuto passi da gigante nella diagnosi e trattamento di molte patologie, la relazione terapeuta-paziente è stata troppo spesso trascurata dalla medicina moderna. Eppure le parole contano. Le moderne neuroscienze ci possono oggi descrivere cosa succede nel cervello del paziente quando interagisce con il proprio terapeuta. Per farci capire tutto ciò, l’effetto placebo è un eccellente esempio di come l’interazione fra colui che cura e colui che soffre produce cambiamenti nel cervello che possono essere benefici. Le condizioni più studiate sono il dolore e i disordini del movimento, come la malattia di Parkinson, dove le vie biochimiche implicate sono state identificate e analizzate in dettaglio. Ciò che sta emergendo è che questa interazione speciale e unica, dove il paziente crede e spera, attiva gli stessi meccanismi che sono attivati dai farmaci. Anzi, sarebbe meglio dire il contrario: sono i farmaci che attivano gli stessi meccanismi delle parole, visto che queste ultime sono nate prima nel corso dell’evoluzione. Maggiore è l'interazione fra il terapeuta e il suo paziente, maggiore la probabilità di successo di una terapia. Perché le parole sono farmaci, e sono spesso tanto importanti quanto le molecole.
Ausbildung
Lehrerinnen und Lehrer
Benedetti Fabrizio
Education
1981 M.D. degree, University of Turin Medical School
1984-85 Silbert Scholarship, Psychiatry and Biobehavioral Sciences, University of California, Los Angeles
Positions and Employments
1983 Research Associate, Neurophysiology, University of Turin Medical School
1986-90 Assistant Professor of Physiology, University of Turin Medical School
1991-1992 Assistant Professor of Pharmacology, University of Texas, Dallas
1992-99 Associate Professor of Neurophysiology and Human Physiology, University of Turin Medical School
1999-today Professor of Neurophysiology and Human Physiology, University of Turin Medical School
2014-today Chairman of Clinical Research and Neurotherapeutics, “Innovative Clinical Trials & Healthcare” Initiative
2014-today Director of Medicine and Physiology of Hypoxia, Breuil-Cervinia/Zermatt, Italy/Switzerland
Consultant activity at the National Institute of Health (NIH), Bethesda, MD, USA
2000-2002 Co-chair of the Breakout Group of the NIH for the development of “Recommendations for research to further elucidate the nature of the placebo effect”.
2003 Member of the Working Group of NIDA for planning a research agenda on the “Recovery of brain structure and function through behavioral treatments”.
2004 Member of the Task Force of NIMH on “Brain mechanisms in the placebo response”.
2004-2009 Member of the Brain-Body-Behavior Research Group of NCCAM for developing a strategic planning process for 2005-2009.
Consultant activity at Harvard University, Cambridge, MA, USA
2010-today Consultant and Advisory Board of PIPS School, Harvard Medical School.
Invited Professional Memberships
2001-2007 Member of the Placebo Working Group of the “Mind-Brain-Behavior” Initiative at Harvard University, Cambridge, MA, USA
2002-today Member of the European Working Group on Pain and Impaired Cognition
2006-2010 Member of the Board of the Placebo Group of the International Association for the Study of Pain
Awards
1984 Silbert International Award at the University of California Los Angeles
1985 Italian Angelo Costa Prize for Physiology
1997 Novartis Prize of the Italian Society for Neuroscience
2009 Medical Books Award of the British Medical Association
2012 Seymour Solomon Award of the American Headache Society
2012 Herlitzka Prize for Physiology, Academy of Sciences, Turin
2015 William S Kroger Award of the American Society of Clinical Hypnosis
2015 EFIC-IBSA Award for the best paper in the Eur J Pain.
2018 ARNo Award from Neurological Research Association, University of Pisa
Academy and organizations nominations
2010-today Nominated member of the Academy of Europe (Medicine & Physiology section)
2010-today Nominated member of the European Dana Alliance for the Brain
2015-today Nominated member of the Council of Scientists of the Human Frontiers Science Program Organization
Editorial Boards
Seminars in Pain Medicine (2001-2003)
Open Anesthesiology Journal (2005-2006)
Pain (2009-2015)
Current Neuropharmacology (2009-today)
Canadian Journal of Pain (2016-today)
Organization of International conferences
2007 Co-organizer (together with Manfred Schedlowski, Germany and Paul Enck, Germany) of the international meeting “Mechanisms of Placebo/Nocebo Responses”, Nov. 28-30,
2007, Tutzing, Germany
2008 Co-organizer (together with Damien Finniss, Australia, Donald Price, USA, and Ron Kupers, Denmark) of the 12th World Congress on Pain Satellite Meeting “The placebo effect – Advances in research and implications for clinical trials and clinical practice”, Aug. 14-15, 2008, Copenhagen, Denmark.
2011 Organizing Committee of the 8th IBRO World Congress of Neuroscience, July 2011, Florence, Italy.
2013 Co-organizer (together with Manfred Schedlowski, Germany and Paul Enck, Germany) of the International Meeting on Placebo, 23-25 Jan 2013, Tuebingen, Germany
Hauptinformationen
|
Morgen
|
08:00 - 09:00
|
| Italiano | |
| Keine | |
| Mitglied |
25.00 CHF
|
| Nicht-Mitglied |
35.00 CHF
|
| Assistent |
15.00 CHF
|